Differential changes in phospholipase D and phosphatidate phosphohydrolase activities in ischemia-reperfusion of rat heart

被引:14
作者
Asemu, G
Dent, MR
Singal, T
Dhalla, NS
Tappia, PS [1 ]
机构
[1] Univ Manitoba, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci, Dept Human Nutrit Sci,Fac Human Ecol, Winnipeg, MB R2H 2A6, Canada
[2] Univ Manitoba, Dept Physiol, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci,Fac Med, Winnipeg, MB R2H 2A6, Canada
基金
加拿大健康研究院;
关键词
cardiac ischemia-reperfusion; sarcolemma; sarcoplasmic reticulum; phospholipase D; phosphatidate phosphohydrolase; phosphatidic acid; diacylglycerol;
D O I
10.1016/j.abb.2005.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phospholipase D (PLD2) produces phosphatidic acid (PA), which is converted to 1,2 diacylglycerol (DAG) by phosphatidate phosphohydrolase (PAP2). Since PA and DAG regulate Ca2+ movements, we examined PLD2 and PAP2 in the sarcolemma (SL) and sarcoplasmic reticular (SR) membranes from hearts Subjected to ischemia and reperfusion (I-R). Although SL and SR PLD2 activities were unaltered after 30 min ischemia, 5 min reperfusion resulted in a 36% increase in SL PLD2 activity, whereas 30 min reperfusion resulted in a 30% decrease in SL PLD2 activity, as compared to the control value. SR PLD2 activity was decreased (39%) after 5 min reperfusion, but returned to control levels after 30 min reperfusion. Ischemia for 60 min resulted in depressed SL and SR PLD2 activities, characterized with reduced V-max and increased K-m values, which were not reversed during reperfusion. Although the SL PAP2 activity was decreased (31%) during ischemia and at 30 min reperfusion (28%), the SR PAP2 activity was unchanged after 30 min ischemia, but was decreased after 5 min reperfusion (25(V,)) and almost completely recovered after 30 min reperfusion. A 60 min period of ischemia followed by reperfusion caused an irreversible depression of SL and SR PAP2 activities. Our results indicate that I-R induced cardiac dysfunction is associated with subcellular changes in PLD2 and PAP2 activities. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 57 条
[41]  
PITTS BJR, 1979, J BIOL CHEM, V254, P6232
[42]   REGULATION BY HYPOXIA OF ENDOTHELIN-1-STIMULATED PHOSPHOLIPASE-D ACTIVITY IN SHEEP PULMONARY-ARTERY CULTURED SMOOTH-MUSCLE CELLS [J].
PLEVIN, R ;
KELLOCK, NA ;
WAKELAM, MJO ;
WADSWORTH, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) :311-315
[43]   SIGNAL-TRANSDUCTION PATHWAYS OF ANGIOTENSIN-II-INDUCED C-FOS GENE-EXPRESSION IN CARDIAC MYOCYTES IN-VITRO - ROLES OF PHOSPHOLIPID-DERIVED 2ND MESSENGERS [J].
SADOSHIMA, J ;
IZUMO, S .
CIRCULATION RESEARCH, 1993, 73 (03) :424-438
[44]   Cytosolic phospholipase A(2), (PLA(2)), but not secretory PLA(2), potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells [J].
Sapirstein, A ;
Spech, RA ;
Witzgall, R ;
Bonventre, JV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) :21505-21513
[45]  
SERHAN C, 1981, J BIOL CHEM, V256, P2736
[46]   Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy [J].
Tappia, PS ;
Maddaford, TG ;
Hurtado, C ;
Dibrov, E ;
Austria, JA ;
Sahi, N ;
Panagia, V ;
Pierce, GN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (01) :280-289
[47]   Depressed responsiveness of phospholipase C isoenzymes to phosphatidic acid in congestive heart failure [J].
Tappia, PS ;
Yu, CH ;
Di Nardo, P ;
Pasricha, AK ;
Dhalla, NS ;
Panagia, V .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (03) :431-440
[48]   Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart [J].
Temsah, RM ;
Netticadan, T ;
Chapman, D ;
Takeda, S ;
Mochizuki, S ;
Dhalla, NS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (02) :H584-H594
[49]   Diacylglycerol - when is it an intracellular messenger? [J].
Wakelam, MJO .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1998, 1436 (1-2) :117-126
[50]   Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy [J].
Williams, SA ;
Tappia, PS ;
Yu, CH ;
Bibeau, M ;
Panagia, V .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (01) :109-118